Oncology

Nathan Merrill, University of Michigan, Ann Arbor, USA, presents his work on a precision medicine-based platform, which is used to…

Chiara Cremolini and Julien Taieb discuss the most important updates in BRAF V600E-mutated metastatic colorectal cancer (mCRC) research…

Our latest webinar explores precision oncology in the form of biomarkers and treatments for non-small cell lung cancer. Francesco…

This webinar explores treatment decisions for patients with metastatic renal cell carcinoma. The expert faculty will discuss the main…

Find out how Daiichi Sankyo scientists are uncovering new ways to address needs in cancer.

Watch our latest webinar on-demand now, exploring the ways in which clinical decision making is affected by long term outcomes in…

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…

The presentation focused on advancing the treatment of oestrogen-receptor positive (ER+) human epidermal growth factor receptor…

Watch our latest webinar on muscle invasive bladder cancer (MIBC), which outlines the journey of patients with MIBC, and key treatment…

Explore the significance of homologous recombination deficiency (HRD) in ovarian cancer. This fantastic webinar delves into methods and…

Experience a fresh take on cancer therapies as we bring you the latest symposium from the European Society for Medical Oncology’s (ESMO)…

This webinar will explore the impact of long term outcomes in clinical trials on clinical decision making.

In this webinar, Francesco Passiglia, MD, Associate Professor of Medical Oncology. University of Turin will summarize the complex landscape of the NSCLC precision oncology biomarkers and treatments.

This webinar will present a short overview of when it is important to consider comprehensive genomic profiling (CGP) and its role in clinical research of solid tumors.

At the European Society for Thoracic Surgeons (ESTS) 2023 Conference Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt…

Access the exclusive video of Boehringer Ingelheim’s Industry Sponsored Symposium at the International Association for the Study of Lung…

This webinar will explore current treatment options for patients with muscle-invasive urothelial carcinoma.

This webinar takes a retrospective look at the use of monoclonal antibody biosimilars in the treatment of breast cancer.

Dr Alberto Bossi. During EAU23 in Milan, Dr Alberto Bossi discusses the most recent advances in treatments for localised disease.

Prof. Bernd Schmitz-Dräger. On the third day of EAU23 in Milan, Professor Bernd Schmitz-Dräger presents highlights from the congress in advanced hormone sensitive prostate cancer treatment.

Professor Peter Hammerer. On the final day of EAU23 in Milan, Professor Peter Hammerer provides updates from the congress on screening, early detection and advanced prostate cancer.

With the growing number of young patients who have survived cancer, onco-fertility care has become an essential aspect of cancer disease management. This webinar explores the different aspects involved in onco-fertility care, including fertility risk, prevention strategies, and pregnancy planning.  

Chaired by Prof. Andrea Necchi, this symposium presented by Prof. Rouprêt and Prof. Retz explores the treatment landscape for muscle-invasive urothelial carcinoma, as well as their perspectives on future treatment landscape.

Originally presented at ESMO Congress 2022, Incyte’s satellite symposium featured educational presentations from an esteemed faculty of experts including Professor Juan Valle (Co-chair; UK), Dr David Malka (Co-chair; France), Professor Filippo de Braud (Italy), Dr Angela Lamarca (Spain) and Dr Antoine Hollebecque (France).

This webinar will educate you on how the biology of a breast tumour reveals additional information that can support choosing the best treatment plan. It will specifically focus on now-a-days clinical dilemmas, like what is the best treatment for pre-menopausal patients, what is the optimal duration of endocrine therapy and how can I find those nasty tumours. The dilemmas are discussed with the help of cases.

Watch this webinar on BRAF V600E mutant metastatic colorectal cancer (mCRC), chaired by therapeutic leaders in the field Professor Fortunato Ciardiello and Professor Chaira Cremolini.

Not able to attend the Expert Roundtable Discussion in Paris? Access the on-demand webcast here. This interactive event features expert perspectives on current and emerging uses of BTK inhibitors for CLL and MCL. Topics include:

Interactive webinar designed for doctors treating breast cancer interested in advancing personalized treatment through molecular gene expression testing.

This recent hybrid satellite symposium, presented at the European Society for Medical Oncology (ESMO) 2022 Congress, addressed the current clinical practice for the management of patients with METexon14 (METex14) non-small cell lung cancer (NSCLC).

The 37th Annual European Association of Urology (EAU) Congress 2022 in Amsterdam, the Netherlands, where data from the CLEAR study, a Phase III randomised controlled trial evaluating lenvatinib plus pembrolizumab combination therapy against sunitinib as first-line treatment in patients with advanced renal cell carcinoma, were presented.

This symposium session presented at the ESMO 2022 included presentations exploring different and new aspects of treating patients.

A multidisciplinary team (MDT) approach is considered the gold standard for the diagnosis and treatment of cancer. The objectives of this webinar are to: Summarise key changes in MDT practice in the past and the lessons learned and benefits derived from these changes

A multidisciplinary team (MDT) approach is considered the gold standard for the diagnosis and treatment of cancer.

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content

This webinar covers the current data and ongoing research on neoadjuvant treatments for different breast cancer subtypes.

A virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh exploring latest data and impact of MammaPrint®️ and BluePrint®️

Discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges…

This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.

A multidisciplinary team (MDT) approach is considered the gold standard for diagnosis and treatment of cancer.

This webinar will explore the current evidence and management of head and neck cancer especially focusing on older adults. The speaker…

Presented by: Chair: Dr. Jonathan Sackier, Speakers: Dr. William Audeh, Dr. Alberto Montero

Novartis sponsored ESMO 2021 Satellite Symposium: Navigating the Current Treatment Landscape Faculty: Prof Eric…

This webinar discusses the increased incidence of venous thromboembolism in cancer patients and the safe and effective use of oral anticoagulants to improve outcomes.

Chaired by Prof Alberto Sobrero, we hear from Vassiliki Fotaki and Zorana Maravic from Digestive Cancer Europe (DiCE) as well as GI oncologist, Prof Eric Van Cutsem.

Prof Alberto Sobrero, Prof Per Pfeiffer, and Dr Chiara Cremolini will discuss (i) how the guidelines serve clinicians; (ii) what the guidelines do not and cannot tell us; and (iii) how you would change the current version of the ESMO guidelines in 2021.

This webinar dives into recent developments in pancreatic cancer, featuring a panel of renowned experts including chairperson, Eric van Cutsem (Belgium)…

APEX is an educational and scientific platform that brings you cutting-edge prostate cancer information with real-world implications. APEX brings you highlights from the key conferences, together with expert webinars and discussions that inform everyday clinical practice.

Hear from a panel of renowned gastrointestinal cancers cancer experts, including chairperson Prof Eric van Cutsem (Belgium), Dr Elizabeth Smyth (UK)…

Hear from a panel of renowned colorectal cancer experts, including Prof Alberto Sobrero, Dr Chiara Cremolini, and Dr Dominik Modest, who provide an overview of the current challenges in mCRC…

In this webinar, the expert speakers will provide an overview of recent developments in the therapeutic management of patients with gastric cancer and their implication on clinical practice.

Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature in this webinar.

Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application held in…

CGP enabled by next-generation sequencing (NGS) technology allows all known biomarkers to be evaluated in a single test.

Catch up on this year’s European Society for European Society for Medical Oncology (ESMO) annual congress, with our inside look at the Internationales…

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center…

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK…

In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded…

Interview with Prof. Marie-Pia d’Ortho.

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…

At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…

At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…

Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…

Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…

A biosimilar can be defined as a biological product that demonstrates no clinically meaningful differences to an approved biological product. At the…

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Janice Tsang, MBBS…

Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Atsushi Ohtsu, MD, PhD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD…

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste…